All posts by: Michael Zand

About Michael Zand

Stem cell jabs could reverse ovary disorder – The Times

Continue reading

2017-11-02 NEWS

The Times

Stem cell jabs could reverse ovary disorder
The Times
An ovarian disorder that affects as many as one in five teenage girls and young women may be reversed by injecting them with their own stem cells, scientists have suggested. Polycystic ovary syndrome occurs when a woman’s egg sacs swell with fluid and …

Continue reading

2017-11-02 NEWS

Chicago Tribune

Baby gene therapy study offers hope for fatal muscle disease
Chicago Tribune
Dr. Jerry Mendell of the Center for Gene Therapy at Nationwide Children’s Hospital in Columbus, Ohio, on led a small study of gene therapy in babies born with a usually fatal neuromuscular disease. The study reported Nov. 1, 2017, that the experiment …
Gene Therapy, New Drug Battle a Rare But Deadly Disease in KidsPhilly.com
The Most Expensive Drug in the World Is About to Be Made Worthless by Gene TherapyNewsweek
Phase 1 study shows encouraging data for gene replacement therapy for SMA type IMedical Xpress
The Columbus Dispatch –Business Wire (press release)
all 103 news articles »
Continue reading

2017-11-01 NEWS

Newsweek

Baby gene therapy study offers hope for fatal muscle disease
ABC News
A first attempt at gene therapy for a disease that leaves babies unable to move, swallow and, eventually, breathe has extended the tots’ lives, and some began to roll over, sit and stand on their own, researchers reported Wednesday. Only 15 babies with …
Gene Therapy, New Drug Battle a Rare But Deadly Disease in KidsU.S. News & World Report
The Most Expensive Drug in the World Is About to Be Made Worthless by Gene TherapyNewsweek
New gene-replacement therapy shows promise for kids with neuromuscular diseaseThe Columbus Dispatch
SMA News Today –Fox Business –Genetic Engineering & Biotechnology News
all 8 news articles »
Continue reading

2017-11-01 NEWS

Endpoints News

AveXis offers compelling reasons for a fast FDA OK for gene therapy to treat spinal muscular atrophy in infants
Endpoints News
But in a small Phase I study of 15 patients treated with AveXis’ $AVXS gene therapy for SMA, all of the patients were able to reach 20 months without the need for constant respiratory support, or dying. And many achieved improvements in motor symptoms, …

Continue reading

2017-11-01 NEWS

U.S. News & World Report

Baby Gene Therapy Study Offers Hope for Fatal Muscle Disease
U.S. News & World Report
In this image provided by Nationwide Children’s Hospital, Dr. Jerry Mendell of the Center for Gene Therapy at Nationwide Children’s Hospital in Columbus, Ohio. Mendell led a small study of gene therapy in babies born with a usually fatal neuromuscular …
Gene Therapy, New Drug Battle a Rare But Deadly Disease in KidsU.S. News & World Report
The Most Expensive Drug in the World Is About to Be Made Worthless by Gene TherapyNewsweek
Phase 1 study shows encouraging data for gene replacement therapy for SMA type IMedical Xpress
The Columbus Dispatch –Fox Business –Genetic Engineering & Biotechnology News
all 13 news articles »
Continue reading

2017-11-01 NEWS

Science Magazine

Gene therapy’s new hope: A neuron-targeting virus is saving infant lives
Science Magazine
The results of the trial Evelyn participated in have blown away gene therapy researchers, too, marking one of the once-troubled field’s most dramatic successes yet. All 15 babies treated for SMA1, expected to die by age 2, are alive at 20 months or